Please assess the completion status of the following clinical trial:

Trial Title: Local Anesthetics for Pain Reduction Prior to IV Line Placement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females \> 18 y.o.~* Ability to speak, read, an/or understand English~* Ability to communicate a level of pain via the specified pain scale~* A written order exists for an intravenous peripheral catheter insertion for the patient~Exclusion Criteria:~* Lidocaine allergy~* Buffered lidocaine allergy~* Benzyl alcohol allergy~* Non-English speaking~* Non-responsive or unable to understand or report pain score (ex. intubated in the ICU)~* Inability to place catheter

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): 1% Lidocaine for injection, 0.50 mL administered one time intradermally in peripheral forearm
- Buffered Lidocaine (Type: EXPERIMENTAL): 1% Buffered Lidocaine for injection, 0.50 mL administered one time intradermally in peripheral forearm~Buffered lidocaine is compounded by the following process:~2.3 mLs of 8.4% sodium bicarbonate is added to a vial of 1% lidocaine
- Bacteriostatic Normal Saline (Type: EXPERIMENTAL): Bacteriostatic Normal Saline for injection, 0.50 mL administered one time intradermally in peripheral forearm

Based on this trial design, predict the completion outcome and termination type (if applicable).